In Vitro Diagnostics And IVD Quality Control Industry | Forecast 2030
In Vitro Diagnostics And IVD Quality Control Industry Data Book Covers In Vitro Diagnostics & IVD Quality Control Markets.
The global In Vitro Diagnostics (IVD) and IVD quality control markets combine to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period.
Grand View Research’s In Vitro Diagnostics and IVD quality control industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, volumetric analyses, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.
In Vitro Diagnostics Market Insights
The global in vitro diagnostic market size was valued at USD 132.95 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of -2.8 % from 2023 to 2030.
The reagents products segment led the global market in 2022 and accounted for the largest revenue share of more than 65.00%. The region is expected to retain its dominance growing at the second-fastest CAGR during the forecast period owing to the extensive R&D initiatives being undertaken by major market players for the development of novel reagents.
The growth in precision medicine is projected to enhance the overall demand for such novel reagents and consumables. Players are aligning their instrument launches in line with the increasing genetic test requirement globally.
The molecular diagnostics application segment held the highest market share of 40.92% in 2022 owing to the launch of novel products and continuous evolution in technology. Although PCR usually needs complex equipment, research efforts in this segment have given rise to innovations, such as plasmofluidic chips, which are the size of a postage stamp.
Based on end-uses, the global market has been further sub-segmented into hospitals, laboratories, home care, and others. The laboratory end-use segment led the global market in 2022 and accounted for the highest revenue share of more than 41.00%. An increase in awareness about personalized medicine, a rise in demand for affordable services, and technological advancements are some of the key factors expected to boost the growth of the laboratory segment.
The point-of-care test location segment held the largest revenue share of more than 20.75% in 2022. The demand for point-of-care tests and devices is rising owing to the increased demand for rapid identification of diseases in close proximity to patients to facilitate faster decision-making. This trend is pushing the manufacturers to launch small, transportable, fast, and easy-to-use instruments, making use of these instruments easier in non-laboratory settings.
The infectious disease application segment held the highest market share of 63.66% in 2022. IVDs enable the detection of microorganisms that cause infectious diseases. The most common life-threatening infections are HIV/AIDS, tuberculosis, hepatitis, and pneumonia. Furthermore, key market players are entering into a collaboration to improve access to high-quality, innovative laboratory services for patients & healthcare providers.
Access the Global In Vitro Diagnostics And IVD Quality Control Industry Data Book, 2022 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory & technological framework studies
IVD Quality Control Market Insights
The global In-Vitro Diagnostics quality control market size was valued at USD 905 million in 2018 and is anticipated to register a CAGR of 4.1% over the forecast period.
The immunology application segment led the global market in 2018. Immunology includes the study of the molecular mechanism for understanding the function of the immune system. It majorly involves the mechanism of action of antigens, antibodies, and their interactions. Key applications of the immunochemistry include detection of infectious microorganisms, such as viruses, bacteria, and fungus, by detecting the presence of their toxins and coat antigens.
Molecular diagnostics is anticipated to be the fastest-growing segment at a CAGR of 5.2% over the forecast period. It is a set of complex tests for a medical diagnosis for all major viral, bacterial, and parasitic infections. The introduction of advanced technologies, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), has helped overcome the drawbacks of traditional systems.
Quality Control (QC) was the largest revenue-generating segment in 2018 and is anticipated to be the fastest-growing segment over the forecast period. IVDs fall under the category of medical devices and, hence, are regulated for quality by the FDA. In U.S. QC refers to the procedures monitoring work processes, detecting problems, and making corrections before delivery of products or services.
Hospitals segment was the largest end-use segment in 2018 and is likely to retain the position in the future owing to a rising number of admissions and better reliability of healthcare professionals on clinical diagnosis for deciding treatment alternatives. Hospitals have a separate department for diagnostic services. The tests and instruments in this department need to be monitored regularly, which will augment the market growth.
In Vitro Diagnostics And IVD Quality Control Market – Global Industry Segmentation
In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)
- Instruments
- Reagents
- Services
In Vitro Diagnostics And IVD Quality Control - Segment Analysis, By Technology, 2018 - 2030 (USD Million)
- Immunoassay
- Hematology
- Clinical Chemistry
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
- Infectious Disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Disease
- Drug Testing
- Others
In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By End-use, 2018 - 2030 (USD Million)
- Hospitals
- Laboratories
- Home Care
- Others
In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Million)
- Point of Care
- Home Care
- Others
In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By IVD Quality Control Services, 2018 - 2030 (USD Million)
- Quality Controls
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
- Quality Assurance Services
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
- Data Management
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
Order your copy of the Free Sample of “In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030” Data Book, published by Grand View Research
In Vitro Diagnostics And IVD Quality Control Industry Data Book Regional Outlook
- North America
- S.
- Canada
- Europe
- K.
- Germany
- France
- Italy
- Spain
- Russia
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa (MEA)
- South Africa
- United Arab Emirates
- Saudi Arabia
In Vitro Diagnostics And IVD Quality Control Industry Data Book Competitive Landscape
Additionally, these players are large and established and hence can innovate to sustain a competitive edge. This in turn offers the leading players to capitalize on consolidation opportunities in the market.
Key players operating in the in vitro diagnostics and IVD quality control industry are –
- Una Health Ltd.
- Diachel Diagnostics S.A.
- BHR Diagnostics Pvt. Ltd.
- MD Doctors Direct GmbH
- Axon Lab AG
- Rafer, S.L.
- CTK Biotech, Inc.
- Diagnostic BioSystems
- Scientific Equipment Company
- Stat Services Inc.
Go through the table of content of In Vitro Diagnostics And IVD Quality Control Industry Data Book to get a better understanding of the Coverage & Scope of the study
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sampleThe regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
The QC schemes are appropriate to plasma-based, whole blood-based and serum-based products.
In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testingApplication InsightsThere are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology.
11 February 2020 - The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-marketThe regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testingApplication InsightsThere are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology.
The home care market segment is anticipated to observe a lucrative progression owing to the persistent increase in the usage devices for point-of-care testing.
This analysis of the Global In-Vitro Diagnostics (IVD) Quality Control Market aims to offer relevant and well-researched insights into the contemporary market scenario and the emergent growth dynamics.
The report on In-Vitro Diagnostics (IVD) Quality Control Market also gives the market players and fresh contenders a holistic view of the global market landscape.
The comprehensive study will help both established and emerging players formulate lucrative business strategies and realize their short-term and long-term goals.The In-Vitro Diagnostics (IVD) Quality Control industry has witnessed a stable growth rate in the past decade and is expected to continue on the same path in the forthcoming decades.
Therefore, it is crucial to recognize all investment opportunities, potential market threats, restraining factors, challenges, market dynamics, and technological development to intensify footholds in the In-Vitro Diagnostics (IVD) Quality Control sector.
This report has evaluated all the above mentioned aspects to present a detailed assessment to the reader to assist them in achieving the desired growth in their businesses.Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/1508Companies profiled for this market studyAgilent Diagnostics, Abbott Diagnostics, Becton, Dickson and Company, Bio-Rad Laboratories, Inc., and ThermoFisher ScientificFor the purpose of the study, this Reports and Data has segmented the Global In-Vitro Diagnostics (IVD) Quality Control Market on the basis of product type, manufacturer type, design, application, end user and the regional outlook:Product Type (Revenue, USD Million; 2016–2026)Quality ControlsWhole Blood-based ControlsSerum-based ControlsPlasma-based ControlsUrine-based ControlsOther IVD Quality ControlsData Management SolutionsQuality Assurance ServicesManufacturer Type (Revenue, USD Million; 2016–2026)Instrument Manufacturer ControlsIndependent Manufacturer ControlsThird-party ControlsInstrument Specific Manufacturer ControlsApplication (Revenue, USD Million; 2016–2026)Clinical ChemistryImmunochemistryHaematologyMolecular DiagnosticsCoagulation/HaemostasisMicrobiologyOthersEnd User (Revenue, USD Million; 2016–2026)HospitalsClinical LaboratoriesHome CareOthersClick here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/1508Table of Contents:Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global In-Vitro Diagnostics (IVD) Quality Control market, duration considered, and objectives of the research.
Additionally, it segments the market on the basis of product type and application.Executive Summary: It offers a summary of other key studies, annual growth rate, competitive landscape, driving factors, market trends and issues, and macroscopic indicators.Production by Region: Here, the report delivers information related to import and export, production, revenue, and key players of all regional markets inspected in the report.Profile of Manufacturers: Each firm profiled in this segment is investigated by means of SWOT analysis, available products, global production, value, capacity, and other crucial factors.Highlights the following key factors:1) Business description-Detailed description of a firm’s operations and business segments.2) Corporate strategy – Analyst’s summarization of the company’s business strategy.3) SWOT Analysis – A detailed analysis of the company’s strengths, weaknesses, opportunities, and challenges.4) Company history – A company’s evolution, highlighting its key events through the years.5) Major products and services – A list of flagship products, services, and brands of the company.6) Key competitors – A list of key competitors of the company.7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.8) Detailed financial ratios for the past five years – The latest financial ratios derived from annual financial statements released by the company in the last five years.Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe growth of this market across the globe is dependent on multiple factors; including consumer base of several In-Vitro Diagnostics (IVD) Quality Control products, inorganic growth models adopted by companies, price volatility of feedstocks, and product innovation, along with their economic prospects in both producer and consumer nations.Overall, this report provides a clear view of every vital factor of the market without the need to refer to any other research reports or data sources.
Global In-Vitro Diagnostics (IVD) Quality Control Market Forecast to 2028 encompasses crucial data about the global In-Vitro Diagnostics (IVD) Quality Control market and includes a thorough examination of technological development, market drivers, market share, market size, and regional segmentation.
The report also provides a comprehensive evaluation of the market trends, vital statistical data, accurate market estimations, and the key suppliers and manufacturers of the In-Vitro Diagnostics (IVD) Quality Control market.The report is also attuned with the currently ongoing COVID-19 pandemic and its effect on the key segments of the market.
The report is updated with the impact of COVID-19 crisis, economic landscape, and present and future impact of COVID-19 on the market.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Randox Laboratories Ltd., Technopath Clinical Diagnostics, Fortress Diagnostics, Roche Diagnostics, Bio-Techne Corporation, Danaher Corporation, SeraCare Life Sciences Inc.The report also covers a comprehensive analysis of the strategic alliances such as mergers and acquisitions, joint ventures, partnerships, collaborations, agreements, government and corporate deals, and product launches and brand promotions.
The report also offers a thorough analysis of the product portfolios, production capacity, gross margins, revenues, and costing of the key manufacturers and vendors.
Furthermore, it also covers SWOT analysis and Porter’s Five Forces Analysis to offer a deeper insight into the competitive landscape of the market.By Product & Service Type (Revenue, USD Million; 2018-2028)Quality Control ProductsWhole Blood-based ControlsSerum/Plasma-based ControlsUrine-based ControlsData Management SolutionsQuality Assurance ServicesSource-based IVD Quality ControlsBy Manufacturer (Revenue, USD Million; 2018-2028)Third-Party Control ManufacturersOriginal Equipment Manufacturers (OEMs)Instrument-Specific ControlsIndependent ControlsBy Application (Revenue, USD Million; 2018-2028)Immunochemistry/ImmunoassayCoagulation & HemostasisMolecular DiagnosticsClinical ChemistryMicrobiologyHematologyOthersBy End-user (Revenue, USD Million; 2018-2028)HospitalsHome CareClinical LaboratoriesAcademic & Research InstitutesContract Research Organizations (CROs)IVD ManufacturersOthersBrowse Complete Report “In-Vitro Diagnostics (IVD) Quality Control Market” @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
